Diabetes1+2 apoptosis cells

Through polymerization and self assembly The production of insulin within the cell and the utilization of insulin in the glucose transport system to function at a healthy rate through self-assembly and polymerization induce the stem cells to produce insulin add to induce a glucose transport system to be infused with insulin to conduct itself in the nondiabetic fashion

Posted in Uncategorized | Leave a comment

Gliomas research technique2

Induced apoptosis of the glioma the subsequent inducement of death in cellular techniques of the glioma to prevent it from spreading the subsequent capture of metastasis of the glioma in the brain to prevent it from spreading the subsequent calibration of blood vessels to prevent the blood vessels from Supplying the main tumour and spreading the access to cells be genetics evolved of the molecular biology be supra molecular biology of the glioma with particle physics Overall all techniques of prevention of spreading of the glioma by harvesting technology that involve holographic displays encapturement encasement and dissolving of trace criteria of the glioma trace elements holograms and Nanomedicine

Posted in Uncategorized | Leave a comment

Gliomas research technique1

The recalibration realignment the restoration and be re-organization by reversal of engineering reverse engineering of glioma be technique of taking apart the disease and restoring it without its dangerous intention or it’s viral load The possibility of reengineering the glioma to be less invasive to have less of a impact on the brain to be manageable by miniaturization by scattering by dispersal by dissolving by dissipation

treatment by immunoglobulin M

Posted in Uncategorized | Leave a comment

Gliomas research technique

Integration of stem cells with proper medicated techniques with proper preventative techniques of stem cells with proper genetic alterations integration of stem cells with proper anti-bodies chemotherapy drugs at preventative measures to correct the sequences of events which take place in the brain when the glioma is present the integration of stem cells for the prevention of the regrowth of a glioma in the brain CRISPER techniques to minimally invasive surgeries to correct chromosomal alignment and sequences . Treatment with immunoglobulin  M.


Posted in Uncategorized | Leave a comment

Removal of the genetics of a glioma

From the remaining residue of the successful surgery for glioma the removal of the disease part of the brain due to the fact that this can be utilized in the lab to find out the correct genetics the correct epi-genetics The correct sequence is events that lead to the proliferation of the glioma and the effect that it should constitute a growth in the brain the correct genetics the correct sequences the removal of those glioma causation agents and the subsequent repair by stem cell integration as well as self assembly and polymerization after genetic surgery removing the cause and purpose of the glioma.


Levin VA1.
Author information
1Neuro-Oncology Unit 431, University of Texas, M.D. Anderson Cancer Center, Houston 77230-1402, USA.
Gliomas are a family of primary central nervous system tumors of variable malignancy that are derived from supporting glia (astrocytes, oligodendrocytes, ependymal cells) or their progenitors/stem cells. There are two potential strategies to prevention: preventing gliomas from forming and preventing lower-grade gliomas from developing into higher-grade gliomas. Each would lower time-dependent mortality. Each also depends on an understanding of what causes gliomas so that these factors can be modulated. In this presentation, I will discuss primary prevention, chemoprevention, and screening. I will first focus on the known chromosomal, genetic, and protein changes associated with the different histologic varieties of glioma and the environmental, hereditary, and infectious/viral factors that may promote glioma development and malignant progression. I will discuss a number of clinical scenarios that eventuate from the known genetic patterns of these tumors and the changes in genetic patterns that reflect malignant progression. The basic thinking is that if one could prevent specific gene mutations and/or deletions or gains of specific chromosomes that lead to the development of low-grade (WHO 2) gliomas, then theoretically this would reduce the occurrence of high-grade (WHO 3 and 4) gliomas and hence the almost certain death that now is the fate of most patients with these tumors. In the case of de novo WHO 3 and 4 tumors, being able to prevent or counter specific gene mutations and/or the deletion of specific chromosomes would in itself reduce the occurrence of these gliomas and increase survival. Alternatively, a curative treatment for low-grade glioma that prevents these chromosomal/gene changes would prevent some glioblastomas (WHO 4) from forming and would have the same desired effect on survival. Obviously, for the latter to be achieved, we must also be able to diagnose and treat low-grade gliomas earlier.


So will be preventable status would be incurred after the surgery to in sure that the gliomas do not regrow the preventable techniques would be incurred of a chromosome level of genetic level to ensure that the genetics would be safe and secure in the future for the plug to stop the proliferation of the glioma


Steroids are commonly administered for the control of edema, mass effect, and side effects from therapy to patients with malignant glioma who are receiving radiotherapy and chemotherapy. Here, we report that therapeutic concentrations of dexamethasone (DEX) attenuate cytotoxicity and growth inhibition of human malignant glioma cells induced by exposure to several chemotherapeutics, including ACNU, VM-26, vincristine, cytarabine, metho-trexate, and adriamycin. DEX-mediated cytoprotection is not linked to DEX effects on glioma cell proliferation. However, the cytoprotective effects of DEX appeared to be more prominent in cell lines with wild-type p53 status (n = 2) than in p53 mutant cell lines (n = 3). Further, DEX-mediated rescue from chemotherapy does not directly involve Bcl-2 family proteins since DEX failed to change the expression of Bcl-2 or Bax proteins and since bcl-2 gene transfer-mediated cytoprotection was not redundant with the effects of DEX. DEX thus appears to control a common, bcl-2-independent death pathway in glioma cells that is not limited to specific drug actions. Chemotherapy is usually given as an elective, adjuvant treatment to glioma patients in stable condition who can tolerate steroid withdrawal. To maximize therapeutic I efficacy, steroids should be withdrawn from glioma patients prior to chemotherapy.

© 1997 by the American Academy of Neurology

Posted in Uncategorized | Leave a comment

New Diving Mask

instead of wearing a diving mask snorkel or oxygen tank could be as a patent to the diving mask of the mouthpiece be that the mouthpiece integrates with the sea water and picks the oxygen out of the water out of the H2O combination and leaves only oxygen for the person to breathe screening out the seawater leaving a breathable apparatus with only a mask at mouthpiece needed for deep-sea diving reef diving scuba

Posted in Uncategorized | Leave a comment

Equipment support continued

Consideration of AI and modules of holographic implementation for specific special effects for specific special integration for specific calibration with nature and science the allocation of super hearing super smelling super tasting super seeing and super thinking super touching super feeling The adaptation of utilizing the techniques for the technology of stem cell fusion reanimation and repair the adaptation of utilizing the technology to correct gliomas and tumours to correct and downstage cancer using the technology to correct for diseases allergies illnesses disorders and other medical malformations the correction of the anatomy from head to toe the correct alignment of all anatomical systems for homeostasis systems analysis diagnosis and the overall attempt at the technological application to treat and heal in a supportive holographic personalized mechanism

Posted in Uncategorized | Leave a comment